Advertisement
Advertisement

JUNS

JUNS logo

Jupiter Neurosciences, Inc. Common Stock

0.59
USD
Sponsored
-0.02
-3.69%
Feb 06, 15:58 UTC -5
Closed
exchange

After-Market

0.60

0.00
+0.67%

JUNS Earnings Reports

Positive Surprise Ratio

JUNS beat 2 of 4 last estimates.

50%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Jupiter Neurosciences, Inc. Common Stock earnings per share and revenue

On Nov 14, 2025, JUNS reported earnings of -0.07 USD per share (EPS) for Q3 25, beating the estimate of -0.08 USD, resulting in a 14.22% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -5.22% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Jupiter Neurosciences, Inc. Common Stock reported EPS of -$0.07, beating estimates by 14.22%, and revenue of $0.00, 0% as expectations.
The stock price moved down -5.22%, changed from $1.34 before the earnings release to $1.27 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Jupiter Neurosciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement